UnknownNCT05372302
Collecting Ducts Carcinoma: in Depth Exploration and Biologically Driven Therapy (CICERONE)
Studying Collecting duct carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Principal Investigator
- Filippo De Braud, ProfFondazione IRCCS Istituto Nazionale Tumori - Milano
- Enrollment
- 100 enrolled
- Eligibility
- 18-85 years · All sexes
- Timeline
- 2021 – 2022
Study locations (1)
- Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05372302 on ClinicalTrials.govOther trials for Collecting duct carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06302569Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary CarcinomaGiuseppe Procopio
- RECRUITINGPHASE2NCT06211114Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct CarcinomaPeking University Cancer Hospital & Institute